Evommune
EVMN
$5.28+2.13%
Delayed · as of Oct 19, 2026, 2:00 PM ET
Mkt cap
$191.57M
EV/Sales
11.3
P/E ratio
N/A
FY2025 Revenue
$13.00M
EPS (H1 2026)
$-1.54
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-529.77%
Beta
N/A
Div yield
N/A
Sector
N/A
Evommune (EVMN) common stock.
Latest reported EVMN revenue for 2025-12-31 was $13.0M. Net income was -$68.9M. Revenue was up 85.7% from 2024-12-31 to 2025-12-31. EVMN currently screens at market cap $191.6M.
Use this EVMN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full EVMN income, balance, and cash tables.
Latest cached Evommune (EVMN) revenue for Dec 31, 2025 was $13.0M. Net income was -$68.9M. Statements: https://lician.com/financials/evmn
Evommune (EVMN) market capitalization is $191.6M on the latest cached snapshot.
Evommune (EVMN) cached previous close $5.17; day range $5.13 – $5.43; volume 209,969. Session quote: https://lician.com/quote/evmn
Evommune (EVMN) latest cached earnings event is "EVMN earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached EVMN filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/evmn